Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Jonathan Polak

CEO, MESENTECH INC
Vancouver, British Columbia, Canada
Working with Robert Young who lead discovery at Merck resulting in $80B+ in revenue from development of Singulair®. Vioxx®, Arcoxia®, Previcox®, Tredaptive® and odanacatib • Recipient of Heros of Chemistry award and the Order of Canada award • Two time recipient of Prix Galien (UK and Canada)
Speaking In
[Available On-Demand]
Mesentech has a proprietary bone targeting technology that can deliver small molecules directly to…